Home › Osteosarcoma › Oregon › Portland
Osteosarcoma clinical trials in Portland, OR
3 studies for Osteosarcoma are looking for participants at sites in and around Portland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor
RecruitingPhase 2
- Oregon Health and Science University, Portland
Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
RecruitingPhase 3
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RecruitingObservational study
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
Osteosarcoma trials in other cities
- Memphis, TN10 studies
- Atlanta, GA10 studies
- St. Louis, MO10 studies
- Boston, MA9 studies
- Mountain View, CA8 studies
- Los Angeles, CA7 studies
- Chicago, IL7 studies
- Birmingham, AL7 studies
- Houston, TX7 studies
- Tampa, FL6 studies
- Philadelphia, PA6 studies
- New York City, NY6 studies
Other studies in Portland
- Non-Small Cell Lung Cancer46 studies
- Cancer (all types)34 studies
- Prostate Cancer33 studies
- Breast Cancer33 studies
- Metastatic Cancer29 studies
- Colorectal Cancer28 studies
- Ovarian Cancer27 studies
- Lung Cancer26 studies
- Acute Myeloid Leukemia25 studies
- Endometrial Cancer24 studies
- Head and Neck Squamous Cell Carcinoma19 studies
- Pancreatic Cancer19 studies
From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.